Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBerkeley Eng Regulatory News (BKY)

Share Price Information for Berkeley Eng (BKY)

Share Price is delayed by 15 minutes
Get Live Data
24.40    -0.30 (-1.21%)
Bid:
24.00
Ask:
24.80
Spread: 0.80 (3.333%)
Market Cap: £108.90m
BKY Live PriceLast checked at - London Stock Exchange

Intraday Berkeley Eng Share Chart

Development and Financing Partnership with KEPCO

10 Aug 2010 08:33

RNS Number : 8133Q
Berkeley Resources Limited
10 August 2010
 



10 August 2010

 

BERKELEY RESOURCES LIMITED

 

Development and Financing Partnership with KEPCO for the Salamanca Uranium Project

 

Berkeley Resources Limited (ASX/AIM:BKY) is pleased to announce that it has entered into a non-binding Memorandum of Understanding (MOU) with the Korea Electric Power Corporation (`KEPCO'), to finance and develop the Salamanca Uranium Project.

The Korea Electric Power Corporation is a Korean government invested diversified energy company with assets over $US 80 billion and revenues of over $US 30 billion, on a consolidated basis as of December 31, 2009. The company is involved in the generation, transmission and distribution of electrical power from nuclear, hydro, coal, oil and LNG sources worldwide. KEPCO provides electricity to almost all households in Korea and operates twenty nuclear power plants in the country with six more under construction. The company has over 30,000 employees and is listed on the Korean Stock Exchange and the New York Stock Exchange.

KEPCO will invest, at the Project level only, US$ 70 million for a 35% interest in Berkeley's Salamanca Uranium Project, which comprises of Aguila, Alameda, Retortillo and Villar mining areas. KEPCO will also contribute funding of 35% for the development of the Salamanca Uranium Project assets to bring them into production as well as ongoing operating expenditure.

Berkeley and KEPCO will work together through appropriate Board representation at project level and will regularly review future Capital needs and off-take arrangements as the project development phase progresses.

In return, this agreement provides that KEPCO will execute a proposed offtake agreement to purchase 35% of the Salamanca Uranium Project's U308 production at industry standard terms, based on a mix of spot and term prices.

Mr. Ian Stalker, Managing Director of Berkeley commented:

'The strategic partnership with such a successful industry heavyweight as KEPCO confirms our determination to rapidly develop our Salamanca Uranium Project and be operational by the end of 2012. We are delighted to have this added flexibility in both our financing plan and market awareness, particularly at this stage of our project development. This marks a significant achievement in the progress of Berkeley's development cycle and goes a long way to achieve the development of this unique and strategic Project. Berkeley will also retain 100% of the exploration potential in its extensive portfolio as well as the Gambuta Project, which has a JORC inferred resource of 9.2 Mlbs.'

The transaction is subject to the completion of a final sixty (60) days due diligence by KEPCO, execution and delivery of a Definitive Agreement (DA) within thirty (30) days thereafter and Berkeley and KEPCO Board approvals, as well as the receipt of certain regulatory stock exchange approvals, if required.

 

 

For further information please contact:

 

 

 

Enquiries - Managing Director: Ian Stalker Tel: +34 608 221 497 

RBC Capital Markets: Martin Eales Tel: +44 20 7029 7881

BMO Capital Markets: Robin Birchall Tel: +44 20 7664 8121

Conduit PR Charlie Geller Tel: +44 20 7429 6604

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGRGDIDXBBGGG
Date   Source Headline
29th Apr 20267:00 amRNSQuarterly Report March 2026
28th Apr 20267:00 amRNSCeasing to be a Substantial Holder
11th Mar 20267:00 amRNSHalf Year Accounts
11th Mar 20267:00 amRNSHalf Year Accounts
6th Feb 20267:00 amRNSFiling of US$1.25 Billion Statement of Claim
29th Jan 20267:00 amRNSQuarterly Report December 2025
21st Jan 20267:00 amRNSChange in Substantial Holder Notice
24th Dec 20257:00 amRNSIssue of Shares on Exercise of Unlisted Options
19th Dec 20257:00 amRNSReport on Payments to Governments
19th Dec 20257:00 amRNSReport on Payments to Governments
28th Nov 20257:00 amRNSResults of Annual General Meeting
31st Oct 20257:00 amRNSQuarterly Report September 2025
28th Oct 20257:00 amRNSPositive Met Test Work Results at Conchas
23rd Oct 20257:00 amRNSNotice of AGM
3rd Oct 20257:00 amRNSDate of Annual General Meeting
29th Aug 20257:00 amRNSChange in Substantial Holder Notice
27th Aug 20257:03 amRNS2025 Annual Report
31st Jul 20257:00 amRNSQuarterly Report June 2025
30th Apr 20257:00 amRNSQuarterly Report March 2025
23rd Apr 20257:00 amRNSChange in Substantial Holder
25th Mar 20257:00 amRNSASX Price Query
13th Mar 20257:00 amRNSHalf-year Report
31st Jan 20257:00 amRNSQuarterly Report December 2024
29th Jan 20257:00 amRNSShallow, thick zones lithium, rubidium intersected
27th Dec 20247:00 amRNSReport on Payments to Govts
19th Nov 20247:00 amRNSResult of AGM
30th Oct 20247:00 amRNSQuarterly Report September 2024
17th Oct 20247:00 amRNSNotice of Substantial Holder
9th Oct 20247:00 amRNSNotice of AGM
24th Sep 20247:00 amRNSDate of Annual General Meeting
27th Aug 20247:00 amRNS2024 Annual Report
31st Jul 20247:00 amRNSQuarterly Report June 2024
28th May 20247:59 amRNSRequest for Arbitration Submitted against Spain
26th Apr 20247:00 amRNSBoard Changes
26th Apr 20247:00 amRNSQuarterly Report March 2024
10th Apr 20247:32 amRNSCommencement of Arbitration against Spain
13th Mar 20247:05 amRNSHalf-Year Accounts
30th Jan 20247:00 amRNSQuarterly Report December 2023
2nd Jan 20247:00 amRNSExpiry of Unlisted Options
27th Dec 20237:00 amRNSPermitting update
21st Dec 20237:00 amRNSReport on Payments to Govts
21st Nov 20237:00 amRNSResult of AGM
30th Oct 20237:00 amRNSSeptember 2023 Quarterly
11th Oct 20237:00 amRNSNotice of AGM
22nd Sep 20237:00 amRNSDate of Annual General Meeting
30th Aug 20237:00 amRNS2023 Annual Report
26th Jul 20237:57 amRNSIssue of Unlisted Options
24th Jul 20237:00 amRNSQuarterly Report June 2023
19th Jul 20237:00 amRNSResults of Meeting
19th Jun 20237:00 amRNSNotice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.